Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Tofacitinib is an effective and safe treatment for alopecia areata.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

Selumetinib causes fewer and less severe skin issues in children than binimetinib.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Early treatment with JAK inhibitors leads to better hair regrowth in acute alopecia areata.

Baicalin may effectively treat hair loss by inhibiting 5α-reductase.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

An arthritis drug helped a person with severe hair loss regrow their hair.

Ruxolitinib can help regrow hair in severe alopecia areata.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Ritlecitinib can help about 14,000 people with severe hair loss.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

Tofacitinib may help treat severe hair loss, but more research is needed.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.